Benzimidazole derivatives and their use as protein kinase inhibitors
US7977477B2 · kind B2 · utility
26Cited by
5References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 5, 2004 |
| Grant date | Jul 12, 2011 |
| Priority date | — |
| Expiry date | Mar 4, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds of the formula (I):The compounds have activity against cyclin dependent kinases, glycogen synthase kinase and Auroa kinases and are therefore useful to treat cancer and viral diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.